<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>peptide ELISA | LifeTein Peptide Blog</title>
	<atom:link href="https://www.lifetein.com/blog/tag/peptide-elisa/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.lifetein.com/blog</link>
	<description>LifeTein: Custom Peptide Synthesis Service</description>
	<lastBuildDate>Sun, 17 Nov 2024 03:38:47 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://www.lifetein.com/blog/wp-content/uploads/2023/10/cropped-android-chrome-512x512-1-32x32.png</url>
	<title>peptide ELISA | LifeTein Peptide Blog</title>
	<link>https://www.lifetein.com/blog</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Synthetic Peptides Used for indirect ELISA</title>
		<link>https://www.lifetein.com/blog/synthetic-peptides-used-for-indirect-elisa/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=synthetic-peptides-used-for-indirect-elisa</link>
		
		<dc:creator><![CDATA[LifeTein Peptide]]></dc:creator>
		<pubDate>Wed, 07 Jan 2015 18:25:29 +0000</pubDate>
				<category><![CDATA[Antibody]]></category>
		<category><![CDATA[Peptide]]></category>
		<category><![CDATA[MOG 35-55]]></category>
		<category><![CDATA[MOG peptide]]></category>
		<category><![CDATA[Peptide Antibody]]></category>
		<category><![CDATA[peptide ELISA]]></category>
		<guid isPermaLink="false">http://www.lifetein.com/blog/?p=261</guid>

					<description><![CDATA[<p>Peptides can be used for ELISA assay. A peptide-based indirect ELISA was used to screen a population of 40 Multiple sclerosis patients and 39 healthy controls. The encephalitogenic myelin oligodendrocyte glycoprotein (MOG)35–55 synthetic peptides were synthesized by LifeTein. LifeTein&#8217;s Synthetic &#8230; <a href="https://www.lifetein.com/blog/synthetic-peptides-used-for-indirect-elisa/">Continue reading <span class="meta-nav">&#8594;</span></a></p>
The post <a href="https://www.lifetein.com/blog/synthetic-peptides-used-for-indirect-elisa/">Synthetic Peptides Used for indirect ELISA</a> first appeared on <a href="https://www.lifetein.com/blog">LifeTein Peptide Blog</a>.]]></description>
										<content:encoded><![CDATA[<p><a title="Sandwich ELISA" href="http://lifetein.com/custom_sandwich_ELISA_antibody_pairs_services.html" target="_blank" rel="noopener"><img fetchpriority="high" decoding="async" class="aligncenter size-full wp-image-263" src="http://www.lifetein.com/blog/wp-content/uploads/2015/01/ELISA.gif" alt="ELISA" width="770" height="306" /></a></p>
<p>Peptides can be used for ELISA assay. A peptide-based indirect ELISA was used to screen a population of 40 Multiple sclerosis patients and 39 healthy controls. The encephalitogenic myelin oligodendrocyte glycoprotein (MOG)35–55 synthetic peptides were synthesized by LifeTein.</p>
<h2 style="text-align: center;">LifeTein&#8217;s Synthetic Peptides for ELISA</h2>
<p>All MOG peptides or Mycobacterium avium subspecies paratuberculosis (MAP) peptides were synthesized at &gt;90% purity by LifeTein to make sure the ELISA results are clean and consistent. The plates were coated with peptides. After overnight incubation, the plate was blocked, rinsed, and late react with antibodies according to the protocol. In silico analysis identified two peptides belonging to MAP and BCG, which share sequence homology with MOG(35–55). The peptide-based indirect ELISA data showed that sharing of highly conserved linear amino acidic sequences is necessary to elicit antibody-mediated cross-reactivity.</p>
<p>These findings concluded that the presence of MOG (35–55)-specific antibodies in multiple sclerosis pathogenesis. This can be used as a diagnostic biomarker in multiple sclerosis.</p>
<h3> [PDF] <a href="http://scholar.google.com/scholar_url?url=http://uk.multiplesclerosis.elsevier.cc/system/files/articles/assets/S0022510X14006029/482/main.pdf&amp;hl=en&amp;sa=X&amp;scisig=AAGBfm3pZ_9VPqq1ij1f-ZTEAlmsx5FDHw&amp;oi=scholaralrt">Evaluation of the humoral response against mycobacterial peptides, homologous to MOG35–55, in multiple sclerosis patients</a></h3>
<p>MG Marrosu, LA Sechi &#8211; 2014</p>
<p><strong>&#8230;</strong> All peptides were synthesized at N90% purity commercially (<strong>LifeTein</strong>, South<br />Plainfield, NJ 07080 US). Purified peptides were prepared as [10 mM] stock solutions,<br />and were stored in single- use aliquots at −80 °C. 2.3. ELISA <strong>&#8230;</strong></p>

<p class="has-text-align-center"><a href="https://www.lifetein.com/index.html" target="_blank" rel="noreferrer noopener">Peptide Synthesis Home Page</a></p>
<p><!-- /wp:post-content --> <!-- wp:paragraph --></p>
<p>Our Services:</p>
<p><!-- /wp:paragraph --> <!-- wp:paragraph --></p>
<p><a href="https://www.lifetein.com/peptide-product/covid19products-c-64.html" target="_blank" rel="noreferrer noopener">COVID-19 Services &amp; Products</a></p>
<p><!-- /wp:paragraph --> <!-- wp:paragraph --></p>
<p><a href="https://www.lifetein.com/antibody_services.html" target="_blank" rel="noreferrer noopener">Custom Antibody Services</a></p>
<p><!-- /wp:paragraph --> <!-- wp:paragraph --></p>
<p><a href="https://www.lifetein.com/Rush-Peptide-Synthesis-Service.html" target="_blank" rel="noreferrer noopener">Rush Peptide Synthesis</a></p>
<p><!-- /wp:paragraph --> <!-- wp:paragraph --></p>
<p><a href="https://www.lifetein.com/Peptide-Nucleic-Acid.html" target="_blank" rel="noreferrer noopener">Peptide Nucleic Acids (PNAs)</a></p>
<p><!-- /wp:paragraph --> <!-- wp:paragraph --></p>
<p><a href="https://www.lifetein.com/peptide_synthesis_services.html" target="_blank" rel="noreferrer noopener">Custom Peptide Synthesis Services</a></p>
<p><!-- /wp:paragraph --> <!-- wp:paragraph --></p>
<p><a href="https://www.lifetein.com/protein-expression-service.html" target="_blank" rel="noreferrer noopener">Gene Synthesis Service</a></p>
<p><!-- /wp:paragraph --> <!-- wp:paragraph --></p>
<p><a href="https://www.lifetein.com/custom_chemical_synthesis.html" target="_blank" rel="noreferrer noopener">Custom Chemical Synthesis</a></p>
<p><!-- /wp:paragraph --> <!-- wp:paragraph --></p>
<p>Other Posts:</p>
<p><a href="https://www.lifetein.com/blog/lifetein-peptide-cited-in-cell/">LifeTein Peptide Cited in Cell</a></p>
<p><a href="https://www.lifetein.com/blog/phospho-specific-antibodies-lifetein-published-nature/">Phospho-specific antibodies by LifeTein published in Nature</a></p>
<p><a href="https://www.lifetein.com/blog/synthesis-of-multiple-antigenic-peptidesstrategies-and-limitations/">Synthesis of multiple antigenic peptides: strategies and limitations</a></p>
<p><a href="https://www.lifetein.com/blog/the-structural-basis-of-peptide-protein-binding-strategies/">The Structural Basis of Peptide-Protein Binding Strategies</a></p>
<p> </p>The post <a href="https://www.lifetein.com/blog/synthetic-peptides-used-for-indirect-elisa/">Synthetic Peptides Used for indirect ELISA</a> first appeared on <a href="https://www.lifetein.com/blog">LifeTein Peptide Blog</a>.]]></content:encoded>
					
		
		
			</item>
	</channel>
</rss>

<!--
Performance optimized by W3 Total Cache. Learn more: https://www.boldgrid.com/w3-total-cache/?utm_source=w3tc&utm_medium=footer_comment&utm_campaign=free_plugin


Served from: www.lifetein.com @ 2026-04-14 10:55:04 by W3 Total Cache
-->